Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TMO compared with AZN: revenue, margins and what each company keeps, and the suppliers and customers both name
TMO
Thermo Fisher Scientific Inc.
Change
Mkt cap
Revenue
Revenue
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
vs
Compare
TMO
Thermo Fisher Scientific Inc.
vs
AZN
Astrazeneca PLC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
TMO
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±4.9%
▲
+0.97%
×0.20
Q2 FY26
±4.9%
▲
+8.71%
×1.78
Q1 FY26
±4.1%
▼
−9.20%
×2.24
Jan 29 '26
±3.7%
▼
−2.61%
×0.70
AZN
No earnings history for AZN.
= implied
TMO realized, solid
AZN realized, hatched
One scale, both sides: full bar = 10%
× = |realized| ÷ implied
Source: market data
TMO
Thermo Fisher Scientific Inc.
Change
699.06
▲
+2.40%
Mkt cap
$252.9B
Revenue
$12.1B
Q3 FY26
Revenue
$44.6B
FY25
AZN
Astrazeneca PLC
Change
183.71
▼
−1.54%
Regular session
Nov 3 '26
Mkt cap
$289.4B
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 3 '26
TMO
Thermo Fisher Scientific Inc.
vs
AZN
Astrazeneca PLC
699.06
▲
+2.40%
Price
183.71
▼
−1.54%
$252.9B
Mkt cap
$289.4B
Q3 FY26
$12.1B
Revenue
—
FY25
$44.6B
Revenue
—
Change
Change
TMO
699.06
▲
+2.40%
vs
AZN
183.71
▼
−1.54%
Regular session
Nov 3 '26